Jesus Chamorro

Madrid, MD 28034, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients.

Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients.

Journal: The oncologist

Published: April 15, 2024

Negative association of steroids with immunotherapy efficacy in a multi-tumor cohort: time and dose-dependent.

Negative association of steroids with immunotherapy efficacy in a multi-tumor cohort: time and dose-dependent.

Journal: Cancer immunology, immunotherapy : CII

Published: March 24, 2024

Anthracyclines-induced cardiotoxicity in patients with early breast cancer carrying germline BRCA1/2 mutation: the BRCAN study.

Anthracyclines-induced cardiotoxicity in patients with early breast cancer carrying germline BRCA1/2 mutation: the BRCAN study.

Journal: The oncologist

Published: March 11, 2024

Adoptive T cell therapy for solid tumors: current landscape and future challenges.

Adoptive T cell therapy for solid tumors: current landscape and future challenges.

Journal: Frontiers in immunology

Published: December 08, 2023

BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature.

BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature.

Journal: Cancers

Published: September 25, 2023

Recurrent Glioblastoma: A Review of the Treatment Options.

Recurrent Glioblastoma: A Review of the Treatment Options.

Journal: Cancers

Published: June 28, 2023

Current Landscape of Immunotherapy for Advanced Sarcoma.

Current Landscape of Immunotherapy for Advanced Sarcoma.

Journal: Cancers

Published: March 18, 2023

Case-control study assessing the impact of COVID19 in advanced kidney cancer patients treated with antiangiogenics or immunotherapy: the COVID-REN study.

Case-control study assessing the impact of COVID19 in advanced kidney cancer patients treated with antiangiogenics or immunotherapy: the COVID-REN study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 06, 2023

Maintained complete response to talazoparib in a BRCA-2 mutated metastatic luminal breast cancer: case report and review of literature.

Maintained complete response to talazoparib in a BRCA-2 mutated metastatic luminal breast cancer: case report and review of literature.

Journal: Frontiers in oncology

Published: February 04, 2023

Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors.

Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors.

Journal: Cancers

Published: December 30, 2022

Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas.

Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas.

Journal: International journal of molecular sciences

Published: October 06, 2022

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates.

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates.

Journal: International journal of molecular sciences

Published: September 28, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026